This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Vifor gets exclusive rights to Isotechnika's voclosporin for lupus and nephrology indications
15 May 2012
Isotechnika Inc. (immunomodulating therapies) has granted Vifor Pharma Ltd., the drug business of Galenica Group, exclusive worldwide rights to its lead compound voclosporin for lupus and all proteinuric nephrology indications. The license specifically includes the US, but excludes territories already held by Paladin (Canada, South Africa, and Israel), and 3SBio (China, Taiwan, and Hong Kong).
R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?